Literature DB >> 8632518

Multiple-dose activated charcoal in an accidental vancomycin overdose.

S Kucukguclu1, Y Tuncok, H Ozkan, H Guven, A Uguz, F Maltepe.   

Abstract

BACKGROUND: Multiple-dose activated charcoal may enhance the enterocapillary clearance of vancomycin. CASE REPORT: A 17-day-old female neonate born with congenital meningomyelocele and Arnold-Chiari malformation was iatrogenically overdosed with a 500 mg intravenous bolus of vancomycin during a shunt operation. The Red Man's Syndrome developed within minutes, characterized by sudden hypotension, skin rash and cyanosis. Serum vancomycin level at one hour after the injection was 165.7 micrograms/mL, as measured by an enzyme immunoassay method (EMIT). Multiple dose activated charcoal, 1 g/kg, was first given five hours after injection, and continued every four hours for 12 doses. The half-life of vancomycin during charcoal administration was calculated to be 9.4 h or less than the reported 13.4-33.7 h half-life in normal neonates. The neonate's renal function tests and brainstem auditory responses remained normal.
CONCLUSIONS: Gastrointestinal dialysis with multiple-dose activated charcoal without cathartics appeared to shorten the elimination half-life of vancomycin.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8632518     DOI: 10.3109/15563659609020238

Source DB:  PubMed          Journal:  J Toxicol Clin Toxicol        ISSN: 0731-3810


  7 in total

Review 1.  Neonatal erythroderma: differential diagnosis and management of the "red baby".

Authors:  P H Hoeger; J I Harper
Journal:  Arch Dis Child       Date:  1998-08       Impact factor: 3.791

2.  Intravitreal vancomycin and gentamicin concentrations in patients with postoperative endophthalmitis.

Authors:  I M Gan; J T van Dissel; W H Beekhuis; W Swart; J C van Meurs
Journal:  Br J Ophthalmol       Date:  2001-11       Impact factor: 4.638

3.  Acacia gum supplementation of a low-protein diet in children with end-stage renal disease.

Authors:  Aamir Jalal Al-Mosawi
Journal:  Pediatr Nephrol       Date:  2004-08-04       Impact factor: 3.714

4.  [Neonatal erythroderma: do not ignore an immune deficiency].

Authors:  Aziza El Ouali; Yousra El Boussaadni; Fatima Ailal; Ahmed Aziz Bousfiha; Sihame Dikhaye; Noufissa Benajiba
Journal:  Pan Afr Med J       Date:  2014-08-21

5.  Treatment of paediatric vancomycin intoxication: a case report and review of the literature.

Authors:  Mathieu Lemaire; Bairbre Connolly; Elizabeth Harvey; Christoph Licht
Journal:  NDT Plus       Date:  2010-03-17

Review 6.  Proposal for a 6-step approach for differential diagnosis of neonatal erythroderma.

Authors:  E Cuperus; A Bygum; L Boeckmann; C Bodemer; M C Bolling; M Caproni; A Diociaiuti; S Emmert; J Fischer; A Gostynski; S Guez; M E van Gijn; K Hannulla-Jouppi; C Has; A Hernández-Martín; A E Martinez; J Mazereeuw-Hautier; M Medvecz; I Neri; V Sigurdsson; K Suessmuth; H Traupe; V Oji; S G M A Pasmans
Journal:  J Eur Acad Dermatol Venereol       Date:  2022-03-15       Impact factor: 9.228

7.  Neonatal erythroderma: diagnostic and therapeutic challenges.

Authors:  Sandipan Dhar; Raghubir Banerjee; Rajib Malakar
Journal:  Indian J Dermatol       Date:  2012-11       Impact factor: 1.494

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.